Presidential Lecture Heart Failure as a Maladaptive Consequence of Cardiac
Hypertrophy
Shigetake Sasayama, M.D., Ph.D.
Figure 6. Functional
and hemodynamic parameters were significantly improved with
bosentan and temocapril. Bosentan had no effect on ventricular
mass in contrast to temocapril.
